Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5806854 | Current Opinion in Virology | 2013 | 7 Pages |
Abstract
- The TASHET core promoter element of HIV is required for Tat trans-activation.
- We review the proof-of-principle shown for pharmacological targeting of TASHET.
- Recent findings reveal host cell complexes that specifically recognize TASHET.
- Viral core promoter binding proteins emerge as new targets to control latency.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Emmanuelle Wilhelm, Brendan Bell,